Semaglutide Study Finds Link to Blood Clots A 2021 study published in the Endocrine Journal (Volume 68, Issue 6, pages 739-742) found that type 2 diabetes patients using semaglutide were at a 266% increased risk of deep vein thrombosis
Your team will recommend the right cadence based on your wellness journey
All that having been said, we do believe that starting to feel good about yourself can be a positive catalyst to a lifestyle change and we believe it because weve seen it in our patients
Preclinical studies show GLP-1RAs mitigate ventricular dilation, fibrosis, and hypertrophy via insulin-like growth factor (IGF)-1/2 and -estrogen receptor pathways
This hormone is the master regulator of muscle growth, it facilitates cell proliferation and differentiation
Patients with certain genetic variants may maintain weight more successfully on tirzepatide, while others respond best to semaglutide monotherapy